During the past decade, North Carolina Clinical Research conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 24 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Carolina Clinical Research" #1 sponsor was "Meda Pharmaceuticals" with 10 trials, followed by "Sunovion" with 5 trials sponsored, "Sunovion Respiratory Development Inc." with 4 trials sponsored, "Milton S. Hershey Medical Center" with 3 trials sponsored and "Novartis" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Carolina Clinical Research" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Kramer Consulting, LLC" with 2 trials as a collaborator, "PharPoint Research, Inc." with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Global BioClinical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "North Carolina Clinical Research" are "Asthma" (18 trials), "Seasonal Allergic Rhinitis" (8 trials), "COPD" (6 trials), "Perennial Allergic Rhinitis" (6 trials) and "Chronic Obstructive Pulmonary Disease" (3 trials). Many other conditions were trialed in "North Carolina Clinical Research" in a lesser frequency.

Most popular intervention types in "North Carolina Clinical Research" are "Drug" (50 trials), "Biological" (5 trials), "Device" (2 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "fluticasone propionate" (3 trials), "placebo" (3 trials), "0.15% azelastine hydrochloride" (2 trials) and "SUN-101 50 mcg BID eFlow (CS) nebulizer" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Carolina Clinical Research" are 58 trials for "All" genders.

Currently, there are NaN active trials in "North Carolina Clinical Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in North Carolina Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in North Carolina Clinical Research, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".